ArticleScience immunology2021
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8
Abstract read
In one paragraph
Article in Science immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
119 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2.Virus research · 2023Pooled it
- Antigenic Variation and Immune Recognition Inference From the COVID-19 Pandemic: An In Silico Comparative Analysis of Spike T Cell Epitopes From the SARS-CoV-2 Variants of Concern.Influenza and other respiratory viruses · 2026Article
- AI-aided design of multi-epitope peptide vaccine elicits cellular and humoral immunity to broad Omicron subvariants.Zoological research · 2026Article
- Position-5-driven reorientation of an immunodominant HLA-A*24:02 SARS-CoV-2 epitope drives universal T cell escape.JCI insight · 2026Article
- Article
- Review
- HLA-C-derived peptide MH-1 as an early-stage intervention against SARS-CoV-2 infection.Molecular medicine (Cambridge, Mass.) · 2026Article
- T cell decision-making decodes the dynamic antigenic landscape.Frontiers in immunology · 2026Review
- Resistance potential of the HLA-A2-restricted immunodominant SARS-CoV-2-specific CD8Nature communications · 2025Article
- Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies.Journal of molecular and cellular cardiology · 2025Review
- C > U mutations generate immunogenic peptides in SARS-CoV-2.Nature communications · 2025Article
- Extensive cross-reactive T cell epitopes across SARS-CoV-2 Omicron variant spikes with finite immune evasion mutations.Journal of translational medicine · 2025Article
- Characterization of human CMV-specific CD8Cell reports methods · 2025Article
- In Silico Analysis of Post-COVID-19 Condition (PCC) Associated SNP rs9367106 Predicts the Molecular Basis of Abnormalities in the Lungs and Brain Functions.International journal of molecular sciences · 2025Article
- Population-level toggling of T cell immune escape at human leukocyte antigen anchor residues in SARS-CoV-2 Spike proteins, in an ethnically diverse population region.PLoS computational biology · 2025Article
- The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis.Vaccines · 2025Article
- Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19.JCI insight · 2025Article
- Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development.Biology · 2025Article
- Impaired and restored CD8Frontiers in immunology · 2025Article
- Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity.Frontiers in immunology · 2025Article
59 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors.
Benedikt AgererCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0002-0044-8396
Maximilian KoblischkeCenter for Virology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-1223-4990
Venugopal GudipatiInstitute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6647-0708
Luis Fernando Montaño-GutierrezSt. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.ORCID 0000-0003-2383-1483
Mark SmythCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0003-2592-1722
Alexandra PopaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0001-7156-272X
Jakob-Wendelin GengerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0003-4502-1094
Lukas EndlerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0002-9115-8756
David M FlorianCenter for Virology, Medical University of Vienna, Vienna, Austria.
Vanessa MühlgrabnerInstitute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Marianne GraningerCenter for Virology, Medical University of Vienna, Vienna, Austria.
Stephan W AberleCenter for Virology, Medical University of Vienna, Vienna, Austria.
Anna-Maria HusaSt. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.ORCID 0000-0002-3105-6694
Lisa Ellen ShawDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2273-7655
Alexander LercherCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0003-3478-5304
Pia GattingerDepartment of Pathophysiology and Allergy Research, Division of Immunopathology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6724-8543
Ricard Torralba-GombauCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0002-9498-6717
Doris TrapinInstitute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Thomas PenzCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Daniele BarrecaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0003-3373-9939
Ingrid FaeDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-7698-5526
Sabine WendaDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-0387-6601
Marianna TraugottDepartment of Medicine 4, Clinic Favoriten, Vienna, Austria.ORCID 0000-0003-0534-1966
Gernot WalderDivision of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
Winfried F PicklInstitute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Volker ThielInstitute of Virology and Immunology, Bern and Mittelhäusern, Switzerland.
Franz AllerbergerAustrian Agency for Health and Food Safety (AGES), Vienna, Austria.ORCID 0000-0002-0045-8164
Hannes StockingerInstitute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6404-4430
Elisabeth Puchhammer-StöcklCenter for Virology, Medical University of Vienna, Vienna, Austria.
Wolfgang WeningerDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.
Gottfried FischerInstitute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-3442-3680
Wolfgang HoeplerDepartment of Medicine 4, Clinic Favoriten, Vienna, Austria.ORCID 0000-0003-2653-3844
Erich PawelkaDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-0199-0539
Alexander ZoufalyDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Rudolf ValentaInstitute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID 0000-0001-6091-3088
Wolfgang PasterSt. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.ORCID 0000-0002-5537-2886
René GeyereggerSt. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.ORCID 0000-0002-5762-790X
Matthias FarlikDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-0698-2992
Florian HalbritterSt. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria.ORCID 0000-0003-2452-4784
Johannes B HuppaInstitute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2634-8198
Judith H AberleCenter for Virology, Medical University of Vienna, Vienna, Austria.
Andreas BergthalerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. abergthaler@cemm.oeaw.ac.at.ORCID 0000-0003-0597-1976
Funding
European Research Council 679146
Abstract
CD8
Indexed as
COVID-19Epitopes, T-LymphocyteImmunity, CellularMutationSARS-CoV-2CD8-Positive T-LymphocytesCell ProliferationHigh-Throughput Nucleotide SequencingHLA-A AntigensHumansInterferon-gammaPeptidesEpitopes, T-LymphocyteHLA-A AntigensIFNG protein, humanInterferon-gammaPeptides
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.